About this trial
The goal of this observational study is to describe the demographic, epidemiological, clinical, and outcome characteristics of patients with prostate cancer.
It also aims to analyze the diagnostic approaches and management strategies used in the care of these patients in Algeria.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 19 years and older.
Diagnosis of prostate cancer confirmed histologically and/or biologically.
Patients followed in the participating oncology departments.
Written informed consent obtained.
Disqualifiers
None
Trial population
Patients with histologically and/or biologically confirmed prostate cancer, followed in the participating centers.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Socio-demographic characteristics of patients with prostate cancer in Algeria
Frequency (%) of sociodemographic characteristics of patients with prostate cancer in Algeria, including age at diagnosis, marital status, and socioeconomic level.
Personal and family history of cancer
Frequency (%) of patients with personal and family history of cancer.
Environmental and occupational exposures
Frequency (%) of patients with environmental or occupational exposures.
Smoking history
Frequency (%) of patients according to smoking status (current, former, never).
Secondary outcomes
Diagnosis by PSA testing
% of patients diagnosed by PSA testing.
Diagnosis by imaging
% of patients diagnosed by imaging.
Diagnosis by biopsy
% of patients diagnosed by biopsy.
Time from symptom onset to first medical consultation
Median time (in days) between onset of first symptoms and first medical consultation.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Société Algérienne de Formation et Recherche en Oncologie
Lead sponsor
ES Clinical Research
Collaborator
Ipsen
Collaborator
Astellas Pharma Inc
Collaborator